(Q38912532)

7 September 2017

title

Anti-inflammatory role of DPP-4 inhibitors in a nondiabetic model of glomerular injury (English)

1 reference

7 September 2017

0 references

Yoshiki Higashijima

1

1 reference

7 September 2017

Tetsuhiro Tanaka

2

1 reference

7 September 2017

Junna Yamaguchi

3

1 reference

7 September 2017

Shinji Tanaka

4

1 reference

7 September 2017

Masaomi Nangaku

5

1 reference

7 September 2017

publication date

4 February 2015

1 reference

American Journal of Physiology - Renal Physiology

7 September 2017

published in

1 reference

7 September 2017

volume

308

1 reference

7 September 2017

issue

8

1 reference

7 September 2017

page(s)

F878-87

1 reference

Effects of exenatide on measures of β-cell function after 3 years in metformin-treated patients with type 2 diabetes

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

Anti-proliferative actions of T-type calcium channel inhibition in Thy1 nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

Enzymatic activity of CD26 (dipeptidylpeptidase IV) is not required for its signalling function in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

The novel DPP-4 inhibitors linagliptin and BI 14361 reduce infarct size after myocardial ischemia/reperfusion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

FK506 ameliorates proteinuria and glomerular lesions induced by anti-Thy 1.1 monoclonal antibody 1-22-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

Contrasting effects of steroids and mizoribine on macrophage activation and glomerular lesions in rat thy-1 mesangial proliferative glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

Dipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

Protection of glucagon-like peptide-1 in cisplatin-induced renal injury elucidates gut-kidney connection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

Pharmacokinetic, pharmacodynamic, and efficacy profiles of alogliptin, a novel inhibitor of dipeptidyl peptidase-4, in rats, dogs, and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

Distinct macrophage phenotypes contribute to kidney injury and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

CD26 expression correlates with entry, replication and cytopathicity of monocytotropic HIV–1 strains in a T–cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

Long-term treatment of glucagon-like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

Macrophages and progressive tubulointerstitial disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

Macrophage plasticity and polarization: in vivo veritas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

The effect of glucagon-like peptide 1 on cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

Macrophages promote polycystic kidney disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

Lipopolysaccharide induces macrophage migration via prostaglandin D(2) and prostaglandin E(2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

Eicosapentaenoic acid regulates IκBα and prevents tubulointerstitial injury in kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

The potential for renoprotection with incretin-based drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

CSF-1 signaling mediates recovery from acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

P2Y(6) agonist uridine 5'-diphosphate promotes host defense against bacterial infection via monocyte chemoattractant protein-1-mediated monocytes/macrophages recruitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00590.2014

10.1152/AJPRENAL.00590.2014

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference